The DOI matches its Crossref record; 20 of the 21 references it cites were found in a registry or an index.
Maintenance Fluconazole Therapy for Recurrent Vulvovaginal Candidiasis
Abstract
BACKGROUND: No safe and convenient regimen has proved to be effective for the management of recurrent vulvovaginal candidiasis. METHODS: After inducing clinical remission with open-label fluconazole given in three 150-mg doses at 72-hour intervals, we randomly assigned 387 women with recurrent vulvovaginal candidiasis to receive treatment with fluconazole (150 mg) or placebo weekly for six months, followed by six months of observation without therapy. The primary outcome measure was the proportion of women in clinical remission at the end of the first six-month period. Secondary efficacy measures were the clinical outcome at 12 months, vaginal mycologic status, and time to recurrence on the basis of Kaplan-Meier analysis. RESULTS: Weekly treatment with fluconazole was effective in preventing symptomatic vulvovaginal candidiasis. The proportions of women who remained disease-free at 6, 9, and 12 months in the fluconazole group were 90.8 percent, 73.2 percent, and 42.9 percent, as compared with 35.9 percent, 27.8 percent, and 21.9 percent, respectively, in the placebo group (P< 0.001). The median time to clinical recurrence in the fluconazole group was 10.2 months, as compared with 4.0 months in the placebo group (P<0.001). There was no evidence of fluconazole resistance in isolates of Candida albicans or of superinfection with C. glabrata. Fluconazole was discontinued in one patient because of headache. CONCLUSIONS: Long-term weekly treatment with fluconazole can reduce the rate of recurrence of symptomatic vulvovaginal candidiasis. However, a long-term cure remains difficult to achieve.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although symptom resolution is achieved in ~90% of women with RVVC who undergo ⩾6 months of maintenance therapy,16,21,22 up to 50% will have a recurrence after the termination of maintenance therapy. 13”
From Clinical challenges in diagnosis and treatment of recurrent vulvovaginal candidiasis (2022) · cites this paper as [21]
In the citing paper
“A landmark RVVC treatment study using an induction regimen of fluconazole (three 150 mg doses at 72 h intervals) followed by weekly maintenance doses of 150 mg of fluconazole for 6 months was shown to reduce symptoms and recurrences. 21”
From Clinical challenges in diagnosis and treatment of recurrent vulvovaginal candidiasis (2022) · cites this paper as [21]
In the citing paper
“The mainstay of treatment for most cases of uncomplicated VVC is azole antifungals, which, by inhibiting the fungal enzyme CYP51, prevent the accumulation of fungitoxic sterols [11,34].”
From Treatment of Vulvovaginal Candidiasis—An Overview of Guidelines and the Latest Treatment Methods (2023) · cites this paper as [34]
In the citing paper
“During the treatment phases, relapse rates vary between 21% (Donders et al., 2008a), 57.1% (Sobel et al., 2004), and 71.9% (Bolouri et al., 2009) at 12 months depending upon the characteristics of the therapeutic regimen used, as described in Supplementary Tables 2 and 3 .”
From Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion (2022) · cites this paper as Sobel et al., 2004
In the citing paper
“Likewise, other studies found that up to 50% of women with RVVC relapsed after stopping their maintenance therapy regimen (Sobel et al., 2004; Donders et al., 2008a) or that additional fluconazole therapy was continued for longer than 6 months due to either culture-confirmed VVC recurrence, microbiologically unconfirmed but clinically possible VVC recurrence, or due to patients’ preference to”
From Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion (2022) · cites this paper as Sobel et al., 2004
In the citing paper
“With the regimen proposed by Sobel et al. (Sobel et al., 2004) (150 mg of oral fluconazole or placebo once a week for 6 months, after a successful induction phase), 42.9% of 387 women were still disease free at 12 months, indicating over half relapsed after maintenance therapy with fluconazole was stopped.”
From Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion (2022) · cites this paper as Sobel et al., 2004
In the citing paper
“Median time to clinical and mycological relapse was 10.2 and 8.4 months, respectively.”
From Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion (2022) · cites this paper as Sobel et al., 2004
In the citing paper
“With the regimen proposed by Sobel et al. (Sobel et al., 2004) (150 mg of oral fluconazole or placebo once a week for 6 months, after a successful induction phase), 42.9% of 387 women were still disease free at 12 months, indicating over half relapsed after maintenance therapy with fluconazole was stopped.”
From Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion (2022) · cites this paper as Sobel et al., 2004
In the citing paper
“Although oral fluconazole is highly effective at reducing acute episodes during maintenance therapy, long-term remission after stopping the regimen is only present in about half of patients (Sobel et al., 2004; Donders et al., 2008a).”
From Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion (2022) · cites this paper as Sobel et al., 2004
Citations
Cites
Hepatic Injury Associated With Ketoconazole Therapy
Lewis, J. H., Zimmerman, H. J., Benson, G. D., & Ishak, K. G. (1984) · Gastroenterology · doi:10.1016/s0016-5085(84)80021-9 · Cited by 392
Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis
Sobel, J. D. (1985) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(85)80003-x · Cited by 332
Self-citationImmunopathogenesis of recurrent vulvovaginal candidiasis
Fidel, P. L., & Sobel, J. D. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.3.335 · Cited by 298
Self-citationRecurrent Vulvovaginal Candidiasis
Sobel, J. D. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612043152305 · Cited by 219
Self-citationCandida vaginitis: Self-Reported Incidence and Associated Costs
Foxman, B., Barlow, R., Dʼarcy, H., Gillespie, B., & Sobel, J. D. (2000) · Sexually Transmitted Diseases · doi:10.1097/00007435-200004000-00009 · Cited by 158
Self-citationWeekly Fluconazole for the Prevention of Mucosal Candidiasis in Women with HIV Infection
Schuman, P. C., Capps, L., Peng, G., Vazquez, J., El-Sadr, W. M., Goldman, A. I., Alston, B., Besch, C. L., Vaughn, A., Thompson, M., et al. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-9-199705010-00003 · Cited by 120
Self-citationFoxman, B., MARSH, J. V., Gillespie, B. W., & Sobel, J. D. (1998) · Journal of Women s Health · doi:10.1089/jwh.1998.7.1167 · Cited by 92
Self-citationHouang, E. T., Chappatte, O., Byrne, D., Macrae, P. V., & Thorpe, J. E. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.5.909 · Cited by 76
Epidemiologic characteristics of women with idiopathic recurrent vulvovaginal candidiasis
Spinillo, A., Pizzoli, G., Colonna, L., Nicola, S., Seta, F. D., & Guaschino, S. (1994) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(94)90096-5 · Cited by 72
Management of recurrent vulvovaginal candidiasis with intermittent ketoconazole prophylaxis.
Sobel, J. D. (1985) · PubMed · Cited by 62
Self-citation
Flagged first, then by citations
1 of the 21 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–400 of 489
Bradfield Strydom, M., Walpola, R. L., Khan, S., Ware, R. S., & Tiralongo, E. (2021) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.13376 · Cited by 5
Auffray, J., Biteau, N., Cayrel, A., Dacheux, D., Hsein, H., Tchoreloff, P., & Noël, T. (2025) · Virulence · doi:10.1080/21505594.2025.2569629 · Cited by 5
Sheikh, S., Ahmad, A., Ali, S. M., Paithankar, M., Patel, R. B., Chuadhari, S., Dave, P. M., Bhomia, M. V., Desai, J. Y., Munshi, A., et al. (2023) · Archives of Dermatological Research · doi:10.1007/s00403-023-02583-9 · Cited by 5
Limosilactobacillus fermentum KBL674 Alleviates Vaginal Candidiasis
Jang, S. J., Jo, E. J., Lee, C., Cho, B.-R., Shin, Y. J., Song, J. S., Kim, W.-K., Lee, N., Lee, H., Park, S., et al. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10403-3 · Cited by 5
Jahdi, F., Hamzehgardeshi, Z., Kuolaei, M. D., Vahedi, M., & Goodarzi, S. (2021) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2021/112 · Cited by 5
Vulvovaginal Candidiasis in Postmenopausal Women
Becker, M., & Sobel, R. (2023) · Current Infectious Disease Reports · doi:10.1007/s11908-023-00801-z · Cited by 5
Antifungal susceptibility pattern of Candida spp. isolated from vaginal discharge of pregnant women
Elmanama, A. A., Al-Reefi, M. R., Ahmad, B. R. A. H., Najjar, L. A., & Eita, S. S. A. (2020) · IUG Journal of Natural Studies · doi:10.33976/iugns.28.1/2020/07 · Cited by 5
Dowd, F. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.04897-2 · Cited by 5
Critical factors affecting the adherence of Candida albicans to the vaginal epithelium
El-Din, A.-Z. A. K., Al-Basri, H. M., & El‐Naggar, M. Y. (2012) · Journal of Taibah University for Science · doi:10.1016/j.jtusci.2012.10.001 · Cited by 5
Fischer, G. O., Bradford, J. A., & Margesson, L. J. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781316535844 · Cited by 5
The ReCiDiF method to treat recurrent vulvovaginal candidosis: A friend with benefits
Donders, G. G. G., & Vieira‐Baptista, P. (2018) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12795 · Cited by 5
Sobel, J. D., & Nyirjesy, P. (2020) · Wiley eBooks · doi:10.1002/9781119482598.ch28 · Cited by 5
Self-citationStrydom, M. B., Nelson, T. M., Khan, S. A., Walpola, R. L., Ware, R. S., & Tiralongo, E. (2024) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-024-04999-1 · Cited by 5
Susilawati, S., Rahadiyanto, K. Y., Ramdja, M., Theodorus, T., & Hermansyah, H. (2019) · Biodiversitas Journal of Biological Diversity · doi:10.13057/biodiv/d201040 · Cited by 4
Li, T., Liu, Z., Fan, L., Zhang, Z., Bai, H., Wang, F., Shang, C., Zong, X., & Liu, Y. (2023) · BMC Microbiology · doi:10.1186/s12866-023-02987-7 · Cited by 4
Susilo, J., Setiawati, A., Darmansjah, I., Indarti, J., & Kusuma, F. (2011) · Medical Journal of Indonesia · doi:10.13181/mji.v20i3.453 · Cited by 4
Infecciones vaginales por Cándida: Diagnóstico y tratamiento
Reynaud, A. C. (2015) · Revista Peruana de Ginecología y Obstetricia · doi:10.31403/rpgo.v53i1005 · Cited by 4
Fungal infections of the genitourinary tract
Sobel, J. D. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-5680-5.00026-8 · Cited by 4
Self-citationSexually Transmitted Infections
Greenhouse, P. (2018) · Wiley eBooks · doi:10.1002/9781119211457.ch64 · Cited by 4
Kpongbo, E. A., Djohan, V., Ira-Bonouman, A., Vanga-Bosson, A. H., Kassi, K. F., Abibatou, K., Valérie, A. B.-T., Sébastien, A. M., Christiane, P. K.-B., Hervé, M. E. I., et al. (2018) · Journal of Yeast and Fungal Research · doi:10.5897/jyfr2018.0185 · Cited by 4
Brazilian Protocol for Sexually Transmitted Infections, 2020: infections causing vaginal discharge
de Carvalho, N. S., Eleutério, J., Travassos, A. G., Santana, L. B., & Miranda, A. E. (2021) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-593-2020 · Cited by 4
Vulvar Epithelial Disorders and Other Vulvar Conditions
Boardman, L. A., & Cooper, A. S. (2007) · Elsevier eBooks · doi:10.1016/b978-032303247-6.10017-6 · Cited by 4
Correlates of Vulvovaginal Candidiasis among Attendees of a Special Treatment Clinic in Nigeria
Makanjuola, O. B., Adedokun, B., Fayemiwo, S. A., & Bakare, R. A. (2016) · International STD Research & Reviews · doi:10.9734/isrr/2016/27811 · Cited by 4
Eficacia terapéutica del voriconazol en candidiasis vulvovaginal crónica por Candida glabrata
Moyano, E. G., Lama, A. C., Ballesteros, M. D. F., Navarro, M. L., Casaño, Á. V., & Erchiga, V. C. (2012) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2012.07.004 · Cited by 4
Colombo, A. L., Guimarães, T., Camargo, L. F. A., Richtmann, R., Queiroz‐Telles, F., Salles, M. J. C., da Cunha, C. A., Shikanai‐Yasuda, M. A., Moretti, M. L., & Nucci, M. (2012) · The Brazilian Journal of Infectious Diseases · doi:10.1016/s1413-8670(12)70336-7 · Cited by 4
Lacroix, C., & de Chauvin, M. F. (2008) · EMC - Dermatologie · doi:10.1016/s0246-0319(08)48431-5 · Cited by 4
Sustained Efficacy of Oteseconazole in Women with Recurrent Vulvovaginal Candidiasis
Lederman, S. N., Sobel, R., Sobel, J. D., Curelop, S., & Brand, S. R. (2025) · Journal of Women s Health · doi:10.1177/15409996251394811 · Cited by 3
Self-citationTaura, D., Maje, M., Koki, A., & Musa, M. (2013) · Nigerian Journal of Basic and Applied Sciences · doi:10.4314/njbas.v21i1.5 · Cited by 3
Patient Preferences in the Treatment of Vaginal Candidiasis
Martens, M. G. (2018) · Open Journal of Obstetrics and Gynecology · doi:10.4236/ojog.2018.812116 · Cited by 3
Self-citationPrevious antibiotic treatment as a risk factor for recurrent vulvovaginal candidiasis
Yang, W., Nie, Y., Wang, S., Wang, H., Zhao, E., & Dou, N. (2019) · Clinical Journal of Obstetrics and Gynecology · doi:10.29328/journal.cjog.1001034 · Cited by 3
Chayachinda, C., Thamkhantho, M., Ngamsakulrungroj, P., Leeyaphan, C., & Tulyaprawat, O. (2022) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2022.2035336 · Cited by 3
Sobel, J. D. (2015) · Springer eBooks · doi:10.1007/978-3-319-13090-3_8 · Cited by 3
Self-citationStrydom, M. B., Khan, S. A., Walpola, R. L., Testa, C., Ware, R. S., & Tiralongo, E. (2023) · Women s Health · doi:10.1177/17455057231194138 · Cited by 3
Diagnosis and Treatment of Vulvovaginitis
Zapata, M. R. (2023) · Springer eBooks · doi:10.1007/978-3-031-14881-1_25 · Cited by 3
Antifungal Susceptibility of Oral Candida Species Isolated from Patients with Thalassemia Major
El-Shokry, M. (2017) · Journal of Bacteriology & Mycology Open Access · doi:10.15406/jbmoa.2017.05.00160 · Cited by 3
Brocklebank, A., & Maraj, H. (2013) · InnovAiT Education and inspiration for general practice · doi:10.1177/1755738013479944 · Cited by 3
van Riel, S. J. J. M., Lardenoije, C. M. J. G., Wassen, M. M. L. H., van Kuijk, S. M. J., & Cremers, N. A. J. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-070466 · Cited by 3
Gautam, R., Garg, A. P., & Charan, C. (2013) · Cited by 3
Anderson, S. A. (2007) · Elsevier eBooks · doi:10.1016/b978-0-323-03228-5.50093-8 · Cited by 3
Infections of the Lower and Upper Genital Tracts
Eckert, L. O., & Lentz, G. M. (2012) · Elsevier eBooks · doi:10.1016/b978-0-323-06986-1.00023-8 · Cited by 3
Dowd, F. J. (2007) · Elsevier eBooks · doi:10.1016/b978-008055232-3.60909-2 · Cited by 3
Andes, D. R., & Dismukes, W. E. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6640-7_5 · Cited by 3
Are you a lumper or a splitter?
Ledger, W. J., & Witkin, S. S. (2006) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2006.03.098 · Cited by 3
Sobel, J. D., & Muzny, C. A. (2026) · Sexually Transmitted Infections · doi:10.1136/sextrans-2026-056915 · Cited by 3
Self-citationVulvar Dermatitis: Diagnosis and Management
Geisler, A. N., & Willems, J. J. (2026) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000001006 · Cited by 2
Foessleitner, P. (2024) · Die Gynäkologie · doi:10.1007/s00129-024-05317-8 · Cited by 2
The Role of Resistance in Candida Infections: Epidemiology and Treatment
Sobel, J. D., & Akins, R. A. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-595-8_18 · Cited by 2
Self-citationInfectious Diseases: Superficial Fungal Infections
Motaparthi, K. (2016) · Springer eBooks · doi:10.1007/978-3-319-43630-2_16 · Cited by 2
Fluconazole and Ibuprofen Combination: A Potential Treatment for Mucosal Candidiasis
Shamoushaki, T., & Fozouni, L. (2020) · Medical Laboratory Journal · doi:10.29252/mlj.14.5.25 · Cited by 2
Wei, D., Chen, Y., Chen, Y., Cui, T., Cui, T., & Niu, X. (2024) · Gynecology and Obstetrics Clinical Medicine · doi:10.1136/gocm-2024-000014 · Cited by 2
Exploring the Impact of Non‐Ablative Erbium Laser Therapy on Recurrent Vaginal Candidiasis
Gaspar, A., Calderon, A., Mora, J. V., Silva, J., Juan Fernando Bojanini, B., de Araújo, M. H. M., Geada, L. L., Ivanova, E. P., Helvacıoğlu, Y., Coello, P. P., et al. (2025) · Lasers in Surgery and Medicine · doi:10.1002/lsm.23880 · Cited by 2
Sobel, J. D. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-325-7_7 · Cited by 2
Self-citationHochedez, P., Datry, A., & Caumes, É. (2008) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(08)70614-7 · Cited by 2
Clinical Management of Fungal Biofilm Infections
Ramage, G., Short, B., McKloud, E., Alshanta, O. A., Butcher, M. C., McLean, W., & Brown, J. L. (2022) · Springer series on biofilms · doi:10.1007/978-3-031-10992-8_17 · Cited by 2
Ostrosky‐Zeichner, L., & Sobel, J. D. (2023) · Springer eBooks · doi:10.1007/978-3-031-35803-6_9 · Cited by 2
Self-citationImmunopathogenesis of recurrent genital candidosis in women
Tasić, S., & Miladinović-Tasić, N. (2009) · Medicinski pregled · doi:10.2298/mpns0910427t · Cited by 2
Chronic Vulvovaginal Candidiasis
Kuebrich, C. T. (2004) · New England Journal of Medicine · doi:10.1056/nejm200412093512419 · Cited by 2
ACTIVITY OF ANTIBIOTIC ROSEOFUNGIN AGAINST CLINICAL PATHOGENS OF VAGINAL CANDIDIASIS
САДАНОВ, А. К., Акылова, М. А., Balgimbaeva, A. S., Ibragimova, L., Bekezhanova, T. S., Itemirova, A. O., Жаиковна, Т. З., Sultanova, A. Z., Galimbaeva, R. S., & Trenozhnikova, L. P. (2018) · SERIES OF BIOLOGICAL AND MEDICAL · doi:10.32014/2018.2518-1629.16 · Cited by 1
Edwards, L. (2008) · Elsevier eBooks · doi:10.1016/b978-0-7234-3445-0.10024-4 · Cited by 1
Self-citationRelapsing Vulvovaginal Candidiasis: Treatment with Oxygen Therapy and Hyaluronic Acid
Palmieri, B., Condemi, L., Bertozzi, E., Garoia, F., & Vadalà, M. (2022) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2022.10129 · Cited by 1
paitan, D. R. D., & de la Torre, R. J. M. (2023) · Ciencia Latina Revista Científica Multidisciplinar · doi:10.37811/cl_rcm.v7i5.8332 · Cited by 1
Pathogenetic aspects and modern possibilities of therapy of vulvovaginal candidiasis
Рафиковна, Р. М., Lipova, E. V., & Nyanenko, V. A. (2024) · Vestnik dermatologii i venerologii · doi:10.25208/vdv16820 · Cited by 1
Mi, L., & Zhang, D. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1638454 · Cited by 1
Xia, T., Su, S., Wu, R., Zhan, M., Hu, X., & Huang, H. (2025) · BMC Microbiology · doi:10.1186/s12866-025-04611-2 · Cited by 1
Abdelkader, S. I., Aboelenin, S. A., AbdelHafez, R., & Nabhan, A. F. (2026) · BMC Women s Health · doi:10.1186/s12905-026-04356-8 · Cited by 1
Karo, M. B., Simanjuntak, F. M., Aritonang, T. R., Muhaereni, D., Dea, D., & Maharani, Y. (2026) · Veterinary World · doi:10.14202/vetworld.2026.2931-2950 · Cited by 1
Epidemiology, Diagnostics and Therapy of Vulvovaginal Fungal Infections
Frej−Mądrzak, M., Jama−Kmiecik, A., Górzyńska, A., Wahdan, N., & Nawrot, U. (2026) · Pathogens · doi:10.3390/pathogens15090914 · Cited by 1
Rezidivierende Vaginalinfektionen
Mendling, W. (2009) · Der Gynäkologe · doi:10.1007/s00129-009-2349-3 · Cited by 1
Rosenfeld, J. A. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511642111.013 · Cited by 1
Diseases of the Female Genitalia
Karrer, S. (2021) · Springer eBooks · doi:10.1007/978-3-662-58713-3_78-1 · Cited by 1
Alhussaini, M. S. (2016) · Medical Journal of Indonesia · doi:10.13181/mji.v25i3.1444 · Cited by 1
Idiopathic Recurrent Vulvovaginal Candidiasis
Raphaelids, L. (2016) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2016.11.007 · Cited by 1
Vulvar Pain: From the Diagnosis to Treatment Strategies
Graziottin, A., & Murina, F. (2017) · Springer eBooks · doi:10.1007/978-3-319-42677-8_11 · Cited by 1
Temel, B. R., & Özgüney, I. (2018) · Journal of Materials Science and Chemical Engineering · doi:10.4236/msce.2018.63004 · Cited by 1
Dekker, J., Boeke, A. J. P., Gercama, A. J., Kardolus, G., & Boukes, F. (2011) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-8279-8_80 · Cited by 1
Kalkan, Ü., Yassa, M., Sandal, K., Tekin, A. B., KILINÇ, C., Gülümser, Ç., & Tuğ, N. (2021) · Journal of Experimental and Clinical Medicine · doi:10.52142/omujecm.38.4.11 · Cited by 1
Sobel, J. D. (2011) · Springer eBooks · doi:10.1007/978-3-642-14663-3_46 · Cited by 1
Self-citationUrethritis, Vulvovaginitis, and Cervicitis
Braverman, P. K. (2008) · Elsevier eBooks · doi:10.1016/b978-0-7020-3468-8.50061-4 · Cited by 1
Ahangari, F., Oskouei, B. S., Javadzadeh, Y., Adibpour, M., & Farshbaf‐Khalili, A. (2022) · Current Women s Health Reviews · doi:10.2174/1573404819666221208095337 · Cited by 1
ФАРМАКОТЕРАПИЯ ВУЛЬВОВАГИНАЛЬНОГО КАНДИДОЗА
Ongarbayeva, N. S., Balgimbaeva, A. S., Baimakhanova, B. B., САДАНОВ, А. К., LAKHK, O. N., ORAZYMBET, S. E., Trenozhnikova, L. P., Berezin, V., Bogoyavlenskiy, A. P., & MIRALIMOVA, S. M. (2024) · МИКРОБИОЛОГИЯ ЖӘНЕ ВИРУСОЛОГИЯ · doi:10.53729/mv-as.2024.02.06 · Cited by 1
Pagano, R. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107478084.009 · Cited by 1
Zeynalzadeh, M., Amiri, M. M., Basirat, Z., Sharbatdaran, M., Aklamli, M., & Ali, B. (2009) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 1
Vaginitis, vulvitis, cervicitis and cutaneous vulval lesions
Sobel, J. D. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-04579-7.00049-6 · Cited by 1
Self-citationMylonas, I. G., Bolz, M., Spellerberg, B., Kühn, J., & Friese, K. (2008) · Elsevier eBooks · doi:10.1016/b978-343721741-8.50025-8 · Cited by 1
Vulvovaginal Candidiasis, Desquamative Inflammatory Vaginitis, and Atrophic Vaginitis
Sobel, J. D. (2012) · Sexually Transmitted Diseases · doi:10.1002/9781118314937.ch9 · Cited by 1
Self-citationLactobacillus based treatment of vaginal infections
Pendharkar, S. (2013) · Figshare · Cited by 1
Fluconazole reduced the rate of recurrence of vulvovaginal candidiasis
Harkless, G. (2005) · Evidence-Based Nursing · doi:10.1136/ebn.8.2.49 · Cited by 1
Hochedez, P., Datry, A., & Caumes, É. (2007) · EMC - Traité de médecine AKOS · doi:10.1016/s1634-6939(07)45411-4 · Cited by 1
Fornari, G. (2013) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Taira, C. L. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2013.tde-25112013-111653
Animal Models of Mucosal Candida Infections
Bernardis, F. D., Arancia, S., & Sandini, S. (2010) · Methods in microbiology · doi:10.1016/s0580-9517(10)37014-0
Non-albicans Candida Infections
Sobel, J. D., & Revankar, S. G. (2014) · ASM Press eBooks · doi:10.1128/9781555815592.ch19
Self-citationRecurrent vulvovaginal candidiasis
Buppasiri, P. (2006) · Srinagarind Medical Journal (SMJ) - ศรีนครินทร์เวชสาร
A 30-year-old woman with vaginal itching
Morrell, L. H. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107281936.010
Interventions to improve vaginal health for reducing the risk of HIV acquisition
Nwagbara, B. A., Effa, E., Danladi, A., & Osagie, O. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009869.pub2
Chronisch-rezidivierende vulvovaginale Candidose
Clad, A., & Echle, F. (2013) · Springer eBooks · doi:10.1007/978-3-642-30189-6_26
Riesgo de endometritis posparto asociado a vaginitis/vaginosis tratada
Quevedo, J. M. (2022) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · doi:10.48713/10336_1656
Pritchard, J. (2010) · Practice Nursing · doi:10.12968/pnur.2010.21.9.78089
Metadata
- Authors
- Sobel, J. D., Wiesenfeld, H. C., Martens, M., Danna, P., Hooton, T. M., Rompalo, A., Sperling, M., Livengood, C., Horowitz, B., Von Thron, J., Edwards, L., Panzer, H., & Chu, T.-C.
- Affiliations
- Wayne State University (US)
- University of Pittsburgh (US)
- Hennepin County Medical Center (US)
- University of Washington (US)
- Johns Hopkins University (US)
- Pfizer (United States) (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-08-26
- Volume
- 351
- Issue
- 9
- Pages
- 876-883
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2106311471
- Cited by
- 487
- References
- 21
- Citations by year
- 2026: 12 · 2025: 17 · 2024: 17 · 2023: 26 · 2022: 22 · 2021: 21 · 2020: 22 · 2019: 15 · 2018: 28 · 2017: 30 · 2016: 26 · 2015: 29 · 2014: 23 · 2013: 24 · 2012: 23
- FWCI
- 11.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Health Sciences › Medicine › Urology › Urinary Tract Infections Management
- Keywords
- recurrent vulvovaginal candidiasis, fluconazole, maintenance therapy, Candida albicans, Candida glabrata, antifungal resistance, superinfection, recurrence prevention, clinical remission
- MeSH terms
- Administration, Oral, Adult, Antifungal Agents, Candida albicans, Candidiasis, Vulvovaginal, Double-Blind Method, Drug Administration Schedule, Female, Humans, Remission Induction, Time Factors, Vagina, Fluconazole, Logistic Models, Drug Resistance, Fungal, Candida glabrata, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
